CytRx Corp (NASDAQ:CYTR)
| 2.30 Data as of 1:53pm ET |  -0.01 / -0.43%Today’s Change | 1.59 Today|||52-Week Range 5.50 | +22.99% Year-to-Date |
Latest CYTR News | Press Releases
No recent news for CytRx Corp.
Today’s Trading
| Previous close | 2.31 |
| Today’s open | 2.30 |
| Day’s range | 2.25 - 2.32 |
| Volume | 30,363 |
| Average volume (3 months) | 152,667 |
| Market cap | $70.5M |
| Dividend yield | -- |
Data as of 1:53pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | -1.30% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -60.00% |
| P/E ratio | NM |
| Price/Sales | 429.61 |
| Price/Book | 2.34 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PSDVpSivida Corp | +0.10 | +3.33% |
| LPTNLpath Inc | +0.06 | +1.23% |
| PIPPharmAthene Inc | +0.00 | +0.31% |
| DRIOLabStyle Innovations... | -0.01 | -0.33% |
Data as of 2:17pm ET, 05/23/2013
Financials
| Next reporting date | August 13, 2013 |
| EPS forecast (this quarter) | -$0.15 |
| Annual revenue (last year) | $100.0K |
| Annual profit (last year) | -$18.0M |
| Net profit margin | -17,963.87% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Steven A. Kriegsman, CPA |
Chief Financial Officer & Treasurer John Y. Caloz |
Corporate headquarters Los Angeles, California |
Forecasts
